Case Report : Steroid-induced Ocular Hypertension in a 6-year-old Boy

Copyright © 2021 American Academy of Optometry..

SIGNIFICANCE: Systemic corticosteroid use in children is rare because of known risks of adverse effects. The increased prevalence of multisystem inflammatory syndrome associated with COVID-19 may change this. It is critical for eye care providers to be aware of potential severe and rapid ocular hypertensive response to prevent irreversible vision loss.

PURPOSE: The purpose of this study was to report the importance of early monitoring of intraocular eye pressure in pediatric patients on systemic steroid medication.

CASE REPORT: A 6-year-old White boy presented with a complaint of headache for 2 weeks. He was on his 19th day of treatment for acute lymphoblastic leukemia with oral dexamethasone and chemotherapy. IOP at presentation was 65 mmHg in both eyes measured with iCare tonometry. Treatment with maximum topical glaucoma therapy reduced IOP to normal levels and eliminated the symptom of headache.

CONCLUSIONS: This case reminds eye care providers to be aware of the potential ocular hypertensive response to systemic steroid treatment and the importance of establishing early monitoring. With the emergence of multisystem inflammatory syndrome in children during the current COVID-19 pandemic, eye care providers may encounter more pediatric patients on systemic corticosteroid treatment than previously and should adjust their examinations appropriately.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:98

Enthalten in:

Optometry and vision science : official publication of the American Academy of Optometry - 98(2021), 8 vom: 01. Aug., Seite 867-869

Sprache:

Englisch

Beteiligte Personen:

Tasaki, Anne [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Journal Article
Steroids

Anmerkungen:

Date Completed 07.10.2021

Date Revised 07.10.2021

published: Print

Citation Status MEDLINE

doi:

10.1097/OPX.0000000000001747

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330032135